0 CHECKOUT
Epilepsy Partnering 2010-2015 Product Image

Epilepsy Partnering 2010-2015

  • ID: 2135969
  • March 2015
  • Region: Global
  • 150 Pages
  • CurrentPartnering

The Epilepsy Partnering 2010-2015 report provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in epilepsy partnering deals
Top epilepsy deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

The Epilepsy Partnering 2010-2015 provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of epilepsy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors epilepsy technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of READ MORE >

Note: Product cover images may vary from those shown

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in epilepsy partnering

2.1. Introduction
2.2. Epilepsy partnering over the years
2.3. Epilepsy partnering by deal type
2.4. Epilepsy partnering industry sector
2.5. Epilepsy partnering by stage of development
2.6. Epilepsy partnering by technology type

Chapter 3 – Average deal terms for epilepsy

3.1 Introduction
3.2 Average deal terms for epilepsy
3.3 Epilepsy headline values with median calculation
3.4 Epilepsy upfront values with median calculation
3.5 Epilepsy milestone values with median calculation
3.6 Epilepsy royalty rates with median calculation

Chapter 4 – Active epilepsy dealmakers

4.1. Introduction
4.2 Most active epilepsy dealmakers
4.3. Top epilepsy deals by value
4.4 Big pharma deal activity
4.5 Big biotech deal activity

Chapter 5 – Epilepsy dealmaking directory

5.1. Introduction
5.2. Company A-Z
5.3. By deal type
5.4. By industry sector
5.5. By stage of development
5.6. By technology type

Chapter 6 – Partnering resource center

6.1. Online partnering
6.2. Partnering events
6.3. Further reading on dealmaking

Appendices

Appendix 1 – Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form – Reports
Order Form – Subscription Access Products

Table of figures

Figure 1: Epilepsy partnering since 2010
Figure 2: Epilepsy dealmaking activity– 2010 to 2015
Figure 3: Epilepsy partnering by deal type since 2010
Figure 4: Epilepsy partnering by industry sector since 2010
Figure 5: Epilepsy partnering by stage of development since 2010
Figure 6: Epilepsy partnering by technology type since 2010
Figure 7: Epilepsy deals with a headline value
Figure 8: Epilepsy deals with upfront payment values
Figure 9: Epilepsy deals with milestone payments
Figure 10: Epilepsy deals with royalty rates, %
Figure 11: Top epilepsy deals by value since 2010
Figure 12: Big pharma – top 50 – epilepsy deals 2010 to 2015
Figure 13: Big pharma epilepsy deal frequency – 2010 to 2015
Figure 14: Big biotech – top 50 – epilepsy deals 2010 to 2015
Figure 15: Big biotech epilepsy deal frequency – 2010 to 2015
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

  • Quick Help: A printed copy of the report and CD ROM copy will be shipped to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Corporation
  • Merck & Co., Inc.